Prophase Stock Analysis

PRPH -  USA Stock  

USD 5.92  0.26  4.59%

The current Prophase Labs price drop may encourage stockholders to take a closer look at the company as it is trading at a share price of 5.92 on 226,588 in trading volume. The company executives were unable to exploit market volatilities in May. However, diversifying your overall positions with Prophase Labs can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.52. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Prophase Labs partners.
Please check Your Equity Center.

Search Stock Analysis 

 
Refresh
The Prophase Labs stock analysis report makes it easy to digest most publicly released information about Prophase Labs and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Prophase stock analysis module also helps to analyze the Prophase Labs price relationship with some important fundamental indicators such as market cap and management efficiency.

Prophase Stock Analysis Notes

About 19.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.18. Prophase Labs next dividend is scheduled to be issued on the 2nd of December 2019. The entity had 2:1 split on the 23rd of January 1997. ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements in the United States. ProPhase Labs, Inc. was incorporated in 1989 and is headquartered in Garden City, New York. Prophase Labs operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 95 people. To find out more about Prophase Labs contact Ted Karkus at 215 345 0919 or learn more at http://www.prophaselabs.com.

Prophase Labs Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Prophase Labs' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Prophase Labs or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Prophase Labs generates negative expected return over the last 90 days
Prophase Labs has high historical volatility and very poor performance
The company reported the previous year's revenue of 14.51 M. Net Loss for the year was (2.33 M) with profit before overhead, payroll, taxes, and interest of 4.61 M.
Prophase Labs currently holds about 8.46 M in cash with (2.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.56.
Roughly 19.0% of the company outstanding shares are owned by corporate insiders
Latest headline from www.equities.com: ProPhase Labs Inc falls -3.8980 percent for June 16 - Equities.com

Prophase Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Prophase Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Prophase Labs backward and forwards among themselves. Prophase Labs' institutional investor refers to the entity that pools money to purchase Prophase Labs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Renaissance Technologies LlcCommon Shares290.6 K2.1 M
Vanguard Group IncCommon Shares129.1 K955 K
Wedge Capital Management L L PCommon Shares119 K880 K
Kamunting Street Capital Management LpCommon Shares97.8 K723 K
Bank Of New York Mellon CorpCommon Shares91.1 K674 K
Geode Capital Management LlcCommon Shares81.1 K599 K
Acadian Asset Management LlcCommon Shares61.2 K452 K
Susquehanna International Group LlpPut Options54.6 K404 K
Susquehanna International Group LlpCall Options17.7 K131 K
Note, although Prophase Labs' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Prophase Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 85.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Prophase Labs's market, we take the total number of its shares issued and multiply it by Prophase Labs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Prophase Profitablity

Prophase Labs' profitability indicators refer to fundamental financial ratios that showcase Prophase Labs' ability to generate income relative to its revenue or operating costs. If, let's say, Prophase Labs is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Prophase Labs' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Prophase Labs' profitability requires more research than a typical breakdown of Prophase Labs' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (14.64) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (27.46) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.27.

Management Efficiency

The entity has return on total asset (ROA) of (11.4) % which means that it has lost $11.4 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (21.35) %, meaning that it created substantial loss on money invested by shareholders. Prophase Labs management efficiency ratios could be used to measure how well prophase labs manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 20th of June, Prophase Labs holds the coefficient of variation of (5,641), and Risk Adjusted Performance of (0.002359). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Prophase Labs, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Prophase Labs, which can be compared to its competitors. Please check Prophase Labs variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Prophase Labs is priced some-what accurately, providing market reflects its current price of 5.92 per share. Given that Prophase Labs has jensen alpha of (0.12), we recommend you to check out Prophase Labs's recent market performance to make sure the company can sustain itself at a future point.

Prophase Labs Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Moving Average is predictive technique used to analyze Prophase Labs price data points by creating a series of averages of different subsets of Prophase Labs entire price series. View also all equity analysis or get more info about all moving average overlap studies indicator.

Prophase Labs Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Prophase Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on Prophase Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Prophase Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Prophase Labs Technical and Predictive Indicators

Prophase Labs Forecast Models

Prophase Labs time-series forecasting models is one of many Prophase Labs' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Prophase Labs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Prophase Labs Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Prophase Labs stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Prophase shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Prophase Labs. By using and applying Prophase Stock analysis, traders can create a robust methodology for identifying Prophase entry and exit points for their positions.
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for sexual health Triple Edge XL, an energy booster and testosterone support product and Super ProstaFlow a supplement to support prostate and urinary health under the TK Supplements brand. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution and offers SARS-CoV-2 and COVID-19 viral mutation PCR tests through saliva and nasal swab methods, as well as other respiratory pathogen panel testing services, including Influenza A and B, and others. It serves consumer products companies, as well as large national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was incorporated in 1989 and is headquartered in Garden City, New York.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Prophase Labs to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module
Please check Your Equity Center. Note that the Prophase Labs information on this page should be used as a complementary analysis to other Prophase Labs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Prophase Labs Stock analysis

When running Prophase Labs price analysis, check to measure Prophase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prophase Labs is operating at the current time. Most of Prophase Labs' value examination focuses on studying past and present price action to predict the probability of Prophase Labs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Prophase Labs' price. Additionally, you may evaluate how the addition of Prophase Labs to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
The market value of Prophase Labs is measured differently than its book value, which is the value of Prophase that is recorded on the company's balance sheet. Investors also form their own opinion of Prophase Labs' value that differs from its market value or its book value, called intrinsic value, which is Prophase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prophase Labs' market value can be influenced by many factors that don't directly affect Prophase Labs underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Prophase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine Prophase Labs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prophase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.